|
NL293572A
(enExample)
|
1962-06-07 |
|
|
|
|
US3843681A
(en)
*
|
1971-06-01 |
1974-10-22 |
American Home Prod |
1-carboxamido pyrano(thiopyrano)(3,4-6)indole derivatives
|
|
DE2226703A1
(de)
*
|
1972-05-25 |
1973-12-13 |
Schering Ag |
Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung
|
|
US4057559A
(en)
|
1973-10-01 |
1977-11-08 |
American Home Products Corporation |
Carbazole acetic acid derivatives
|
|
US4810699A
(en)
|
1987-02-20 |
1989-03-07 |
American Home Products Corporation |
Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
|
|
US4782076A
(en)
|
1988-03-01 |
1988-11-01 |
American Home Products Corporation |
Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, composition and use
|
|
PT95692A
(pt)
*
|
1989-10-27 |
1991-09-13 |
American Home Prod |
Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
|
|
US5221678A
(en)
|
1990-07-26 |
1993-06-22 |
Merck Frosst Canada, Inc. |
(quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
|
|
US5998499A
(en)
|
1994-03-25 |
1999-12-07 |
Dentsply G.M.B.H. |
Liquid crystalline (meth)acrylate compounds, composition and method
|
|
US5776967A
(en)
|
1996-07-26 |
1998-07-07 |
American Home Products Corporation |
Pyranoindole inhibitors of COX--2
|
|
US5830911A
(en)
|
1996-08-14 |
1998-11-03 |
American Home Products Corporation |
Pyranoindole and tetrahydrocarbazole inhibitors of COX-2
|
|
US6861448B2
(en)
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
|
JP4038266B2
(ja)
*
|
1998-02-17 |
2008-01-23 |
オイレス工業株式会社 |
粘性せん断型ダンパー
|
|
IL145922A0
(en)
|
1999-04-28 |
2002-07-25 |
Aventis Pharma Gmbh |
Di-aryl acid derivatives as ppar receptor ligands
|
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
|
WO2002039987A2
(en)
|
2000-11-14 |
2002-05-23 |
Neurosearch A/S |
Use of malaria parasite anion channel blockers for treating malaria
|
|
EP1383778B1
(en)
|
2001-01-30 |
2009-10-21 |
University Of Virginia Patent Foundation |
Agonists and antagonists of sphingosine-1-phosphate receptors
|
|
US7534547B2
(en)
|
2001-03-29 |
2009-05-19 |
Osaka Gas Company Limited |
Optically active compound and photosensitive resin composition
|
|
US7179817B2
(en)
|
2001-05-10 |
2007-02-20 |
Ono Pharmaceutical Co., Ltd. |
Carboxylic acid derivatives and drugs containing the same as the active ingredient
|
|
AU2002332289B2
(en)
|
2001-09-27 |
2007-05-10 |
Kyorin Pharmaceutical Co., Ltd. |
Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
|
|
ATE441654T1
(de)
|
2002-01-18 |
2009-09-15 |
Merck & Co Inc |
Edg-rezeptoragonisten
|
|
US20050070506A1
(en)
|
2002-01-18 |
2005-03-31 |
Doherty George A. |
Selective s1p1/edg1 receptor agonists
|
|
JP2005516967A
(ja)
|
2002-01-18 |
2005-06-09 |
ザ ジェネティクス カンパニー インコーポレーティッド |
β−セクレターゼインヒビター
|
|
EP1482896A4
(en)
|
2002-03-01 |
2005-11-23 |
Merck & Co Inc |
AMINO ALKYL PHOSPHONATES AND RELATED COMPOUNDS AS EDG RECEPTOR AGONISTS
|
|
JP2005531506A
(ja)
|
2002-03-01 |
2005-10-20 |
メルク エンド カムパニー インコーポレーテッド |
Ｅｄｇ受容体作動薬としてのアミノアルキルホスホネートおよび関連化合物
|
|
JP2005533058A
(ja)
|
2002-06-17 |
2005-11-04 |
メルク エンド カムパニー インコーポレーテッド |
Ｅｄｇ受容体アゴニストとしての１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）アゼチジン−３−カルボキシラートおよび１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）ピロリジン−３−カルボキシラート
|
|
AU2003252478A1
(en)
|
2002-07-10 |
2004-02-02 |
Ono Pharmaceutical Co., Ltd. |
Ccr4 antagonist and medicinal use thereof
|
|
US7241790B2
(en)
|
2002-07-30 |
2007-07-10 |
University Of Virginia Patent Foundation |
Compounds active in spinigosine 1-phosphate signaling
|
|
EP1559422B1
(en)
|
2002-11-08 |
2014-04-30 |
Takeda Pharmaceutical Company Limited |
Receptor function controlling agent
|
|
JP4516430B2
(ja)
|
2002-12-20 |
2010-08-04 |
メルク・シャープ・エンド・ドーム・コーポレイション |
１−（アミノ）インダン並びに（１，２−ジヒドロ−３−アミノ）−ベンゾフラン、ベンゾチオフェン及びインドール
|
|
JP4505449B2
(ja)
|
2003-02-11 |
2010-07-21 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
新規二環式化合物および組成物
|
|
DK1602660T3
(da)
|
2003-02-18 |
2011-05-23 |
Kyorin Seiyaku Kk |
Aminophosphonsyrederivater, additionssalte deraf og S1P-receptormodulatorer
|
|
ATE547395T1
(de)
|
2003-04-30 |
2012-03-15 |
Novartis Pharma Gmbh |
Aminopropanol-derivate als modulatoren des sphingosin-1-phosphat-rezeptors
|
|
ES2392167T3
(es)
|
2003-04-30 |
2012-12-05 |
Novartis Ag |
Derivados aminopropanol como moduladores del receptor esfingosina-1-fosfato
|
|
JP2006525366A
(ja)
|
2003-04-30 |
2006-11-09 |
ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー |
複素環式カルボン酸置換基
|
|
CA2524867A1
(en)
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
|
|
WO2004104205A2
(en)
|
2003-05-16 |
2004-12-02 |
Merck & Co., Inc. |
Enzymatic preparation of chiral indole esters
|
|
CN1787817B
(zh)
|
2003-05-19 |
2011-09-07 |
Irm责任有限公司 |
免疫抑制剂化合物及组合物
|
|
WO2004113330A1
(en)
|
2003-05-19 |
2004-12-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
MY150088A
(en)
|
2003-05-19 |
2013-11-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
AU2004251146A1
(en)
|
2003-05-19 |
2005-01-06 |
Irm, Llc |
Immunosuppressant compounds and compositions
|
|
GB0313612D0
(en)
|
2003-06-12 |
2003-07-16 |
Novartis Ag |
Organic compounds
|
|
WO2005012221A1
(ja)
|
2003-08-04 |
2005-02-10 |
Ono Pharmaceutical Co., Ltd. |
ジフェニルエーテル化合物、その製造方法および用途
|
|
MXPA06002349A
(es)
|
2003-08-28 |
2006-05-22 |
Novartis Ag |
Derivados de aminopropanol.
|
|
US7825109B2
(en)
|
2003-08-29 |
2010-11-02 |
Ono Pharmaceutical Co., Ltd. |
Compound capable of binding S1P receptor and pharmaceutical use thereof
|
|
US7732442B2
(en)
|
2003-09-05 |
2010-06-08 |
Ono Pharmaceutical Co., Ltd. |
Chemokine receptor antagonist and medical use thereof
|
|
CN1859908A
(zh)
|
2003-10-01 |
2006-11-08 |
默克公司 |
作为s1p受体激动剂的3,5－芳基、杂芳基或环烷基取代的－1,2,4－噁二唑类化合物
|
|
WO2005041899A2
(en)
|
2003-11-03 |
2005-05-12 |
University Of Virginia Patent Foundation |
Orally available sphingosine 1-phosphate receptor agonists and antagonists
|
|
WO2005044780A1
(ja)
|
2003-11-10 |
2005-05-19 |
Kyorin Pharmaceutical Co., Ltd. |
アミノカルボン酸誘導体とその付加塩及びｓ１ｐ受容体調節剤
|
|
AU2004299456B2
(en)
|
2003-12-17 |
2010-10-07 |
Merck Sharp & Dohme Corp. |
(3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists
|
|
JP4766384B2
(ja)
|
2003-12-19 |
2011-09-07 |
小野薬品工業株式会社 |
リゾホスファチジン酸受容体拮抗作用を有する化合物およびその用途
|
|
GB0329498D0
(en)
|
2003-12-19 |
2004-01-28 |
Novartis Ag |
Organic compounds
|
|
GB0401332D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
|
US7718704B2
(en)
|
2004-02-24 |
2010-05-18 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
TWI355934B
(en)
|
2004-02-24 |
2012-01-11 |
Sankyo Co |
Pharmaceutical composition for treatment or prophy
|
|
EP1726585A4
(en)
|
2004-03-05 |
2009-07-15 |
Banyu Pharma Co Ltd |
DIARYLSUBSTITUTED FIVE-GLOSS HETEROCYCLUS DERIVAT
|
|
GB0405289D0
(en)
|
2004-03-09 |
2004-04-21 |
Novartis Ag |
Organic compounds
|
|
CA2561632A1
(en)
|
2004-04-02 |
2005-10-20 |
Merck & Co., Inc. |
Asymmetric hydrogenation process useful for the preparation of cycloalkanoindole derivatives
|
|
WO2005123677A1
(en)
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
|
|
JP5315611B2
(ja)
|
2004-06-23 |
2013-10-16 |
小野薬品工業株式会社 |
Ｓ１ｐ受容体結合能を有する化合物およびその用途
|
|
ATE502630T1
(de)
|
2004-07-16 |
2011-04-15 |
Kyorin Seiyaku Kk |
Verfahren zur effektiven anwendung eines medikaments und verfahren zur prävention von nebenwirkungen
|
|
JP2007284350A
(ja)
|
2004-07-27 |
2007-11-01 |
Takeda Chem Ind Ltd |
糖尿病治療剤
|
|
TW200611687A
(en)
|
2004-07-29 |
2006-04-16 |
Sankyo Co |
Pharmaceutical compositions used for immunosuppressant
|
|
WO2006010379A1
(en)
|
2004-07-29 |
2006-02-02 |
Actelion Pharmaceuticals Ltd. |
Novel thiophene derivatives as immunosuppressive agents
|
|
RU2383536C2
(ru)
|
2004-08-04 |
2010-03-10 |
Тайсо Фармасьютикал Ко., Лтд. |
Производное триазола
|
|
AU2005272619A1
(en)
|
2004-08-13 |
2006-02-23 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (SIP) receptor activity
|
|
US20060223866A1
(en)
|
2004-08-13 |
2006-10-05 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
|
|
US7250441B2
(en)
|
2004-09-23 |
2007-07-31 |
Wyeth |
Carbazole and cyclopentaindole derivatives to treat infection with Hepatitis C virus
|
|
CA2583947A1
(en)
|
2004-10-12 |
2006-04-20 |
Forbes Medi-Tech (Research) Inc. |
Compounds and methods of treating insulin resistance and cardiomyopathy
|
|
JP2008517915A
(ja)
|
2004-10-22 |
2008-05-29 |
メルク エンド カムパニー インコーポレーテッド |
Ｓ１ｐ受容体アゴニストとしての２−（アリール）アザシクリルメチルカルボキシレート、スルホネート、ホスホネート、ホスフィネート及びヘテロ環
|
|
EP1650186B1
(en)
|
2004-10-22 |
2008-06-04 |
Bioprojet |
Novel dicarboxylic acid derivatives
|
|
AU2005307718A1
(en)
|
2004-11-18 |
2006-05-26 |
The Institutes For Pharmaceutical Discovery, Llc |
Heterocycle substituted carboxylic acids for the treatment of diabetes
|
|
US20080051418A1
(en)
|
2004-11-26 |
2008-02-28 |
Tsuyoshi Maekawa |
Arylalkanoic Acid Derivative
|
|
JP2008522977A
(ja)
|
2004-12-06 |
2008-07-03 |
ユニバーシティ オブ バージニア パテント ファンデーション |
スフィンゴシン＝１−リン酸のアリールアミドアナログ
|
|
JP4318087B2
(ja)
|
2004-12-13 |
2009-08-19 |
小野薬品工業株式会社 |
アミノカルボン酸誘導体およびその医薬用途
|
|
WO2006079406A1
(en)
|
2005-01-25 |
2006-08-03 |
Merck Patent Gmbh |
Mesogenic compounds, liquid crystal medium and liquid crystal display
|
|
MX2007009848A
(es)
|
2005-02-14 |
2008-03-10 |
Univ Virginia |
Agonistas de esfingosina 1-fosfato comprendiendo cicloalcanos y heterociclos de 5 miembros substituidos por grupos amino y fenilo.
|
|
BRPI0609668A2
(pt)
|
2005-03-23 |
2011-10-18 |
Actelion Pharmaceuticals Ltd |
composto, composição farmacêutica, e, uso de um composto
|
|
AU2006226018B2
(en)
|
2005-03-23 |
2012-07-12 |
Idorsia Pharmaceuticals Ltd |
Hydrogenated benzo (C) thiophene derivatives as immunomodulators
|
|
KR20080002850A
(ko)
|
2005-03-23 |
2008-01-04 |
액테리온 파마슈티칼 리미티드 |
신규한 티오펜 유도체
|
|
JP2008545767A
(ja)
|
2005-06-08 |
2008-12-18 |
ノバルティス アクチエンゲゼルシャフト |
多環式オキサジアゾールまたはイソキサゾールおよびｓｉｐ受容体リガンドとしてのそれらの使用
|
|
AU2006260573A1
(en)
|
2005-06-24 |
2006-12-28 |
Actelion Pharmaceuticals Ltd. |
Novel thiophene derivatives
|
|
TWI418350B
(zh)
|
2005-06-24 |
2013-12-11 |
Sankyo Co |
含有ｐｐａｒ調節劑之醫藥組成物的用途
|
|
US20070060573A1
(en)
|
2005-08-10 |
2007-03-15 |
Lars Wortmann |
Acyltryptophanols
|
|
JP2009506046A
(ja)
|
2005-08-23 |
2009-02-12 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
免疫抑制剤化合物および組成物
|
|
WO2007037196A1
(ja)
|
2005-09-29 |
2007-04-05 |
Yamamoto Chemicals, Inc. |
インドリン系化合物及びその製造方法
|
|
AR057894A1
(es)
|
2005-11-23 |
2007-12-26 |
Actelion Pharmaceuticals Ltd |
Derivados de tiofeno
|
|
AU2006317689B2
(en)
|
2005-11-23 |
2013-07-25 |
Epix Delaware, Inc. |
S1P receptor modulating compounds and use thereof
|
|
TWI404706B
(zh)
|
2006-01-11 |
2013-08-11 |
Actelion Pharmaceuticals Ltd |
新穎噻吩衍生物
|
|
TW200736234A
(en)
|
2006-01-17 |
2007-10-01 |
Astrazeneca Ab |
Chemical compounds
|
|
KR20080092385A
(ko)
|
2006-01-24 |
2008-10-15 |
액테리온 파마슈티칼 리미티드 |
신규한 피리딘 유도체
|
|
GB0601744D0
(en)
|
2006-01-27 |
2006-03-08 |
Novartis Ag |
Organic compounds
|
|
TWI389683B
(zh)
|
2006-02-06 |
2013-03-21 |
Kyorin Seiyaku Kk |
A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
|
|
TW200806611A
(en)
|
2006-02-09 |
2008-02-01 |
Daiichi Seiyaku Co |
Novel amidopropionic acid derivatives and medicine containing the same
|
|
AU2007212193A1
(en)
|
2006-02-09 |
2007-08-16 |
University Of Virginia Patent Foundation |
Bicyclic sphingosine 1-phosphate analogs
|
|
US20070191371A1
(en)
|
2006-02-14 |
2007-08-16 |
Kalypsys, Inc. |
Heterocyclic modulators of ppar
|
|
CA2642668C
(en)
|
2006-02-15 |
2013-01-08 |
Allergan, Inc. |
Indole-3-carboxylic acid amide and ester compounds bearing phenyl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
|
|
CN101460458A
(zh)
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
|
BRPI0707957A2
(pt)
|
2006-02-21 |
2011-05-17 |
Univ Virginia Patent Found |
composto, e, método para prevenção ou tratamento de uma condição ou sintoma patológico em um mamìfero
|
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
|
CA2646430A1
(en)
|
2006-03-14 |
2007-09-20 |
Amgen Inc. |
Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
|
|
US7790707B2
(en)
|
2006-03-21 |
2010-09-07 |
Epix Pharmaceuticals Inc. |
S1P receptor modulating compounds and use thereof
|
|
JP2007262009A
(ja)
|
2006-03-29 |
2007-10-11 |
Dai Ichi Seiyaku Co Ltd |
ヘテロアリール低級カルボン酸誘導体
|
|
MX2008012738A
(es)
|
2006-04-03 |
2009-02-06 |
Astellas Pharma Inc |
Heterocompuesto.
|
|
GB0607389D0
(en)
|
2006-04-12 |
2006-05-24 |
Novartis Ag |
Organic compounds
|
|
WO2007129473A1
(ja)
|
2006-05-09 |
2007-11-15 |
Daiichi Sankyo Company, Limited |
二環性アリール誘導体
|
|
EP2017263A4
(en)
|
2006-05-09 |
2011-11-30 |
Daiichi Sankyo Co Ltd |
Heteroarylamide derivative of a lower carboxylic acid
|
|
MX2008013990A
(es)
|
2006-05-09 |
2009-01-29 |
Pfizer Prod Inc |
Derivados de cicloalquilamino acidos.
|
|
US20080070866A1
(en)
|
2006-08-01 |
2008-03-20 |
Praecis Pharmaceuticals Incorporated |
Chemical compounds
|
|
AR062156A1
(es)
|
2006-08-01 |
2008-10-22 |
Praecis Pharm Inc |
Compuestos agonistas y selectivos del receptor s1p-1
|
|
EP2099768A2
(en)
|
2006-08-04 |
2009-09-16 |
Praecis Pharmaceuticals Incorporated |
Agonists of the sphingosine-1-phosphate receptor
|
|
US8232319B2
(en)
|
2006-08-08 |
2012-07-31 |
Kyorin Pharmaceutical Co., Ltd. |
Amino phosphate derivative and S1P receptor modulator having same as an active ingredient
|
|
EP2054377A1
(en)
|
2006-08-24 |
2009-05-06 |
Praecis Pharmaceuticals Incorporated |
Chemical compounds
|
|
JP2009269819A
(ja)
|
2006-08-25 |
2009-11-19 |
Asahi Kasei Pharma Kk |
アミン化合物
|
|
CA2662852A1
(en)
|
2006-09-07 |
2008-03-13 |
Allergan, Inc. |
Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity
|
|
CL2007002593A1
(es)
|
2006-09-07 |
2008-06-13 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de 4-heteroaril-piridina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como rechazo de organos transplantados, sindromes autoinmunes y cancer.
|
|
AR061841A1
(es)
|
2006-09-07 |
2008-09-24 |
Actelion Pharmaceuticals Ltd |
Derivados de tiofen-oxadiazoles, agonistas del receptor s1p1/edg1, composiciones farmaceuticas que los contienen y usos como agentes inmunomoduladores.
|
|
CA2662091A1
(en)
|
2006-09-08 |
2008-03-13 |
Novartis Ag |
N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
|
|
EP2069318B1
(en)
|
2006-09-21 |
2012-09-12 |
Actelion Pharmaceuticals Ltd. |
Phenyl derivatives and their use as immunomodulators
|
|
CN101562977A
(zh)
|
2006-12-15 |
2009-10-21 |
艾博特公司 |
新的二唑化合物
|
|
CA2672727A1
(en)
|
2006-12-21 |
2008-07-03 |
Abbott Laboratories |
Sphingosine-1-phosphate receptor agonist and antagonist compounds
|
|
GB0625648D0
(en)
|
2006-12-21 |
2007-01-31 |
Glaxo Group Ltd |
Compounds
|
|
JO2701B1
(en)
|
2006-12-21 |
2013-03-03 |
جلاكسو جروب ليميتد |
Vehicles
|
|
JP2010515750A
(ja)
|
2007-01-11 |
2010-05-13 |
アラーガン インコーポレイテッド |
スフィンゴシン−１−ホスフェート（ｓ１ｐ）受容体アンタゴニスト生物活性を有する６−置換インドール−３−カルボン酸アミド化合物
|
|
WO2008091967A1
(en)
|
2007-01-26 |
2008-07-31 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
WO2008097819A2
(en)
|
2007-02-05 |
2008-08-14 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
JP2010521450A
(ja)
|
2007-03-16 |
2010-06-24 |
アクテリオン ファーマシューティカルズ リミテッド |
Ｓ１ｐ１／ｅｄｇ１受容体アゴニストとしてのアミノ−ピリジン誘導体
|
|
JP5191497B2
(ja)
|
2007-03-21 |
2013-05-08 |
エピックス ファーマシューティカルズ，インコーポレイテッド |
Ｓ１ｐ受容体調節化合物およびその使用
|
|
CL2008001099A1
(es)
|
2007-04-19 |
2008-10-24 |
Glaxo Group Ltd |
Compuestos derivados de indazol; y su uso para tratar enfermedades mediadas por los receptores s1p1, tales como esclerosis multiple, enfermedad autoinmune, trastornos inflamatorios, diabetes, entre otras.
|
|
EP2014653A1
(en)
|
2007-06-15 |
2009-01-14 |
Bioprojet |
Novel dicarboxylic acid derivatives as S1P1 receptor agonists
|
|
US20090069288A1
(en)
|
2007-07-16 |
2009-03-12 |
Breinlinger Eric C |
Novel therapeutic compounds
|
|
WO2009019506A1
(en)
|
2007-08-03 |
2009-02-12 |
Astrazeneca Ab |
Heterocyclyc sulfonamides having edg-1 antagonistic activity
|
|
BRPI0814975A2
(pt)
|
2007-08-08 |
2015-02-03 |
Merck Serono Sa |
Derivados de 6-amino-pirimidina-4-carboxamida e compostos relacionados que se ligam ao receptor de 1-fosfato de esfingosina (s1p) para o tratamento de esclerose múltipla
|
|
UY31468A1
(es)
|
2007-11-15 |
2009-07-17 |
|
Derivados bis-(sulfonilamino) en terapia 065
|
|
AU2008338965A1
(en)
|
2007-12-18 |
2009-06-25 |
Arena Pharmaceuticals, Inc. |
Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
|
|
CA2711887A1
(en)
|
2008-01-25 |
2009-07-30 |
Arena Pharmaceuticals, Inc. |
Dihydro-1h-pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as s1p1 agonists
|
|
AR070398A1
(es)
|
2008-02-22 |
2010-03-31 |
Gruenenthal Chemie |
Derivados sustituidos de indol
|
|
HUE025984T2
(hu)
|
2008-05-14 |
2016-05-30 |
Scripps Research Inst |
Szfingozin foszfát receptor új modulátorai
|
|
WO2009151626A1
(en)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
|
|
WO2009151621A1
(en)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
|
|
HRP20161133T1
(hr)
*
|
2008-07-23 |
2016-12-02 |
Arena Pharmaceuticals, Inc. |
DERIVATI SUSPSTITUIRANE 1,2,3,4-TETRAHIDROCIKLOPENTA[b]INDOL-3-IL-OCTENE KISELINE KORISNI U LIJEČENJU AUTOIMUNIH I UPALNIH POREMEĆAJA
|
|
CN105816453B
(zh)
|
2008-08-27 |
2021-03-05 |
艾尼纳制药公司 |
用于治疗自身免疫性病症和炎性病症的作为s1p1受体激动剂的经取代的三环酸衍生物
|
|
AU2010213794A1
(en)
|
2009-02-10 |
2011-09-01 |
Abbott Laboratories |
Agonists and antagonists of the S1P5 receptor, and methods of uses thereof
|
|
WO2011005290A1
(en)
|
2009-06-23 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Disubstituted oxadiazole derivatives useful in the treatment of autoimmune and inflammatory disorders
|
|
WO2011005295A1
(en)
|
2009-06-24 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto
|
|
CN102686571B
(zh)
|
2009-10-29 |
2015-11-25 |
百时美施贵宝公司 |
三环杂环化合物
|
|
CA2786994C
(en)
|
2010-01-27 |
2018-01-16 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
|
|
CN105503882B
(zh)
|
2010-03-03 |
2019-07-05 |
艾尼纳制药公司 |
制备s1p1受体调节剂及其晶体形式的方法
|
|
EP2598126A2
(en)
|
2010-07-30 |
2013-06-05 |
Saint Louis University |
Methods of treating pain
|